Knight Therapeutics (TSE:GUD)
TSX:GUD
Holding TSE:GUD?
Track your performance easily

Knight Therapeutics (GUD) Balance Sheet

89 Followers

Knight Therapeutics Balance Sheet

Knight Therapeutics's total assets for Q2 2024 were C$945.36M, a decrease of -2.36% from the previous quarter. TSE:GUD total liabilities were C$182.56M for the fiscal quarter, a -11.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
C$ 945.49MC$ 1.05BC$ 991.89MC$ 1.04BC$ 1.31B
Total Liabilities
C$ 198.62MC$ 228.98MC$ 149.87MC$ 153.44MC$ 390.20M
Total Equity Gross Minority
C$ 746.87MC$ 825.86MC$ 842.02MC$ 886.24MC$ 915.11M
Total Capitalization
C$ 790.89MC$ 878.25MC$ 851.28MC$ 886.24MC$ 815.75M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in CAD

Knight Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis